INmuneBIO Company
INmune Bio, Inc. is developing therapies that harness the patients immune system to treat cancer.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
La Jolla, California, United States
Founded Date:
2015
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
2
Total Funding:
$48.2M
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership